Venus Remedies, a leading research-driven pharmaceutical company, has once again received the World Health Organization (WHO) Good Distribution Practices (GDP) certification for its Unit-II supply chain facility in Baddi, Himachal Pradesh. The certification was granted by Société Générale de Surveillance (SGS), a global leader in inspection, testing, and certification services.

This recognition, awarded following a comprehensive and independent audit, affirms Venus Remedies’ unwavering commitment to global pharmaceutical quality standards and distribution best practices. It reflects the company’s continued adherence to international protocols throughout the supply chain—from manufacturing to last-mile delivery.

“This WHO GDP certification is a strategic validation of our capacity to deliver safe, high-quality medicines with transparency and efficiency,” said Saransh Chaudhary, President – Global Critical Care at Venus Remedies and CEO of the Venus Medicine Research Centre. “It is a testament to our operational discipline and our teams’ dedication to continuous improvement and global excellence.”

As part of its broader supply chain transformation, the company has deployed a 360-degree digital logistics ecosystem, integrating IoT-enabled monitoring systems that track temperature, humidity, and shipment location in real time. Proprietary warehousing algorithms have also been developed to optimise cartonisation and shipping workflows—reducing delivery times by half and cutting logistics costs.

To expand direct-to-market outreach, Venus Remedies now operates an online delivery model catering directly to pharmacies and smaller retailers. This system is supported by real-time order tracking, digital payment reconciliation, and live customer support, boosting customer satisfaction and market penetration.

“At Venus Remedies, quality is not confined to manufacturing—it is embedded across the value chain,” said Peeyush Jain, Deputy Managing Director. “The WHO GDP certification reinforces our investment in advanced logistics and highlights our vision to be a reliable global partner in healthcare.”

Venus Remedies holds over 25 Good Manufacturing Practice (GMP) certifications, including a recent approval from Ukraine, underlining its manufacturing excellence. Together with the WHO GDP recognition, these accreditations position the company as a quality-first pharmaceutical leader in both Indian and international markets.